Number of the records: 1
Cytidine deaminase 435CT polymorphism relates to gemcitabine-platinum efficacy and hematological toxicity in Chinese non-small-cell lung cancer patients
SYS 0174089 LBL 00000naa--2200000-a-4500 005 20250607173416.1 008 210728s2021----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Cytidine deaminase 435CT polymorphism relates to gemcitabine-platinum efficacy and hematological toxicity in Chinese non-small-cell lung cancer patients / $c Lili Hu ... [et al.] 300 $b ilustr., aj fareb., grafy, obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d002289 $a karcinóm pľúc, nemalobunkový $x genetika $2 mesh 650 12
$7 sllk_us_auth*d020641 $a polymorfizmus jednonukleotidový $2 mesh 650 22
$7 sllk_us_auth*d003564 $a cytidíndeamináza $x genetika $2 mesh 650 22
$7 sllk_us_auth*d004359 $a farmakoterapia kombinovaná $2 mesh 650 22
$7 sllk_us_auth*d002945 $a cisplatina $2 mesh 653 2-
$a kombinácia gemcitabín a cisplatina 653 2-
$a kombinácia gemcitabín a nedaplatina 653 2-
$a účinnosť liečby 653 2-
$a toxicita chemoterapie 653 2-
$a gén CDA 653 2-
$a vyhodnotenie súboru pacientov 700 1-
$7 sllk_us_auth*0054069 $a Hu, Lili $4 aut 773 0-
$7 nnas $w sllk_us_cat*0173603 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2021 $g Vol. 68, no. 3 (2021), s. 638-644
Number of the records: 1